Bill
HF 3931
Use of spread pricing by pharmacy benefit managers prohibited, license application fees increased, permissible sources of income limited, fiduciary duties imposed, and money appropriated.
2025-2026 Regular Session
Introduced by Kristin Bahner and 3 co-sponsors
Prohibits spread pricing by PBMs and imposes fiduciary duties to act in plan sponsors’ and beneficiaries’ best interests, with stronger oversight.
Introduction and first reading, referred to Health Finance and Policy